Cochlear Ltd (ASX: COH) has seen a significant decline in its share price, dropping 54.2% since the start of 2025. This prompts the question: Is now the time to consider adding COH shares to your investment portfolio? This article delves into the reasons why healthcare stocks, particularly those like Cochlear, are attractive to investors despite the recent price dip.
The Healthcare Sector's Resilience
Healthcare spending is a critical aspect of any economy, as it is essential for maintaining and improving public health. This fundamental nature of healthcare spending makes it one of the last sectors that people cut back on during economic downturns. This 'sticky' revenue stream is a key advantage for healthcare companies, as they are less susceptible to the volatility often seen in other industries.
During the Global Financial Crisis (GFC), healthcare emerged as the best-performing sector, further emphasizing its resilience. This stability in revenue is a significant draw for investors, offering a more predictable and secure investment compared to cyclical businesses.
Growth Potential in Healthcare
The healthcare sector is projected to experience substantial growth, particularly in the United States, which accounts for over 40% of global healthcare spending. Estimates indicate that US healthcare spending will grow at a rate of 7% per year from 2022 to 2027, reaching a staggering US$819 billion. This growth is not limited to the broader healthcare sector but extends to specific sub-sectors, such as healthcare IT, data solutions, and software-as-a-service (SaaS) companies, which are expected to grow their revenue at over 15% per year from 2024 to 2030.
This growth potential is a compelling reason for investors to consider healthcare stocks. The ability to capitalize on the increasing demand for healthcare services and technology is a significant advantage, especially in a rapidly aging global population.
Ethical Investing and Healthcare
The rise of ethical and sustainable investing is another factor that positions healthcare stocks favorably. A Morgan Stanley survey revealed that over half of investors plan to increase their allocation to sustainable investments in 2024. With growing interest in ethical investing, sectors like healthcare, which provide essential public services, are well-positioned to attract new capital and investors.
Cochlear, as a leading medical device company, aligns with the principles of ethical investing. Its focus on enhancing the quality of life for individuals with hearing-related conditions makes it an attractive investment choice for those seeking both financial returns and a positive social impact.
COH Share Price and Valuation
Despite the recent decline, Cochlear's share price is currently trading below its historical average price-to-sales (P/S) ratio. As of the latest data, the P/S ratio is 3.50x, compared to its 5-year average of 9.18x. This suggests that the share price may have fallen, or sales could have increased, indicating a potential opportunity for investors.
However, it's important to note that a single valuation metric should not be the sole basis for investment decisions. The Rask websites offer valuable resources, including free online investing courses and valuation spreadsheets, which can help investors make more informed choices. Models such as Discounted Cash Flow (DCF) and Dividend Discount Models (DDM) provide more comprehensive ways to value the COH share price.
In conclusion, while the decline in Cochlear's share price may be concerning, the healthcare sector's resilience, growth potential, and alignment with ethical investing principles make it an attractive investment opportunity. As with any investment, thorough research and a well-rounded approach are essential to making informed decisions.
